Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
Location: United States, Colorado, Boulder
Employees: 1-10
Total raised: $20.2M
Founded date: 2017
Investors 3
| Date | Name | Website |
| - | Fifty Year... | fiftyyears... |
| 21.07.2020 | Y Combinat... | ycombinato... |
| - | Tencent | tenx.tc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 07.09.2022 | Series A | $17M | - |
| 17.01.2020 | Seed | $3.2M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 07.09.2022 | Arpeggio Biosciences Raises $17M in Series A Funding | Arpeggio Biosciences, a Boulder, CO-based preclinical therapeutics company whose technology targets ... | finsmes.co... |
| 07.09.2022 | Arpeggio Biosciences rakes in $17M to measure the transcript... | How can drug developers design therapies around cellular networks rather than a single target? That... | medcitynew... |
| 15.01.2020 | Arpeggio Bio Secures USD 3.2M in Seed Funding | Arpeggio Bio , a Boulder, Colo.-based preclinical company whose technology provides a mechanistic un... | finsmes.co... |